India to Peru: Pomalidomide Export Trade Route

The India to Peru Pomalidomide corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $658.9K USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's pomalidomide manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $47.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with pomalidomide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #5 among India's top pomalidomide export destinations globally.

On the import side, key buyers of Indian pomalidomide in Peru include MSN LABS PERU SAC, TO THE ORDER OF, DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL and 4 others. MSN LABS PERU SAC is the single largest importer with 6 shipments valued at $454.2K USD.

India's pomalidomide exports to Peru are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, AZISTA INDUSTRIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $47.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pomalid 4 mg (pomalidomide 4mg) (1x21's) and pomalid 4 md pomalidomide 4mg 1x21's, suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MSN LABS PERU SAC is the largest importer with 6 shipments worth $454.2K USD — representing 69% of all pomalidomide imports from India on this route. A total of 7 buyers are active on this corridor.